Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$588.22

24 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $545.74 20
Education $30.06 3
Travel and Lodging $12.42 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $275.59 8
Amgen Inc. $140.39 9
Novo Nordisk Inc $37.45 1
Lilly USA, LLC $31.96 1
SANOFI-AVENTIS U.S. LLC $24.96 1
ABBVIE INC. $22.86 1
PFIZER INC. $19.05 1
Sequel Med Tech, LLC $18.82 1
Corcept Therapeutics $17.14 1

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1447225495?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

24 matching records · $588.22 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 24 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–24 of 24.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sequel Med Tech, LLC $18.8212/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243732145 CMS
Corcept Therapeutics $17.1412/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214213400 CMS
Amgen Inc. $10.0211/25/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1226883117 CMS
Amgen Inc. $3.3411/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227137642 CMS
Amgen Inc. $10.0211/10/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1226894158 CMS
Amgen Inc. $1.0010/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227137644 CMS
Medtronic, Inc. $0.6410/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883852 CMS
Medtronic, Inc. $7.9310/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883854 CMS
Medtronic, Inc. $0.9210/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883850 CMS
Amgen Inc. $10.0209/29/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1226907387 CMS
Medtronic, Inc. $22.7808/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883848 CMS
Medtronic, Inc. $0.8408/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883846 CMS
PFIZER INC. $19.0507/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230235745 CMS
SANOFI-AVENTIS U.S. LLC $24.9607/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233607818 CMS
Medtronic, Inc. $228.6206/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883844 CMS
Lilly USA, LLC $31.9606/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186797477 CMS
Novo Nordisk Inc $37.4506/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188895966 CMS
Amgen Inc. $30.0006/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228656365 CMS
Medtronic, Inc. $12.4206/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1218883842 CMS
ABBVIE INC. $22.8605/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201615107 CMS
Medtronic, Inc. $1.4405/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218883840 CMS
Amgen Inc. $26.2005/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228656371 CMS
Amgen Inc. $23.2204/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228656367 CMS
Amgen Inc. $26.5701/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228656369 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

161 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic, Inc. $268.30 12/31/2023 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993704793
Principal investigator 1 Medtronic, Inc. $3,155.20 12/31/2023 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP337 SUCCEED No dispute reported 06/30/2026 993704797
Principal investigator 1 Medtronic, Inc. $5,863.39 12/31/2023 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CIP341 IMPACT2 No dispute reported 06/30/2026 993704799
Principal investigator 1 Novo Nordisk AS $23.06 12/27/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007323519
Principal investigator 1 Novo Nordisk AS $23.06 12/21/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238609
Principal investigator 1 Novo Nordisk AS $982.80 12/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007969279
Principal investigator 1 Novo Nordisk AS $787.50 12/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985085
Principal investigator 1 Novo Nordisk AS $23.06 12/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985101
Principal investigator 1 Novo Nordisk AS $1,843.33 12/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238569
Principal investigator 1 Novo Nordisk AS $2,850.00 12/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238588
Principal investigator 1 Medtronic, Inc. $6,982.00 12/06/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700613
Principal investigator 1 Novo Nordisk AS $1,417.50 11/27/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007969269
Principal investigator 1 Novo Nordisk AS $23.06 11/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007969247
Principal investigator 1 Novo Nordisk AS $1,081.12 11/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238551
Principal investigator 1 Medtronic, Inc. $838.00 11/20/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697813
Principal investigator 1 Novo Nordisk AS $23.06 11/13/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007969259
Principal investigator 1 Medtronic, Inc. $816.20 10/31/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688033
Principal investigator 1 Medtronic, Inc. $156.00 10/27/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700609
Principal investigator 1 Medtronic, Inc. $1,126.00 10/27/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700611
Principal investigator 1 Novo Nordisk AS $23.06 10/27/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313821
Principal investigator 1 Novo Nordisk AS $354.37 10/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007969289
Principal investigator 1 Novo Nordisk AS $4,257.85 10/20/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238535
Principal investigator 1 Medtronic, Inc. $1,372.00 10/13/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697811
Principal investigator 1 Medtronic, Inc. $1,359.76 10/09/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688031
Principal investigator 1 Novo Nordisk AS $69.16 10/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313833
Principal investigator 1 Novo Nordisk AS $11.82 10/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313843
Principal investigator 1 Novo Nordisk AS $16.40 10/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313853
Principal investigator 1 Novo Nordisk AS $2.97 10/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313865
Principal investigator 1 Novo Nordisk AS $20.00 10/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313875
Principal investigator 1 Medtronic, Inc. $1,533.00 09/25/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697825
Principal investigator 1 Novo Nordisk AS $1,063.12 09/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313809
Principal investigator 1 Novo Nordisk AS $1,118.83 09/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238465
Principal investigator 1 Novo Nordisk AS $7.27 09/21/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701287
Principal investigator 1 Novo Nordisk AS $23.06 09/21/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701297
Principal investigator 1 Medtronic, Inc. $318.00 09/19/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700607
Principal investigator 1 Medtronic, Inc. $424.00 09/15/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694849
Principal investigator 1 Medtronic, Inc. $822.00 09/11/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700605
Principal investigator 1 Novo Nordisk AS $7.27 09/06/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238499
Principal investigator 1 Novo Nordisk AS $23.06 09/06/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238519
Principal investigator 1 Medtronic, Inc. $2,598.16 09/01/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688029
Principal investigator 1 Medtronic, Inc. $126.00 08/29/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694847
Principal investigator 1 Novo Nordisk AS $23.06 08/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701261
Principal investigator 1 Medtronic, Inc. $1,563.00 08/22/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694845
Principal investigator 1 Medtronic, Inc. $5,533.00 08/22/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697823
Principal investigator 1 Novo Nordisk AS $23.06 08/21/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238481
Principal investigator 1 Novo Nordisk AS $1,965.60 08/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313799
Principal investigator 1 Novo Nordisk AS $1,575.00 08/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985053
Principal investigator 1 Novo Nordisk AS $1,405.03 08/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985069
Principal investigator 1 Novo Nordisk AS $3,026.27 08/18/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238449
Principal investigator 1 Medtronic, Inc. $955.00 08/16/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700603
Principal investigator 1 Medtronic, Inc. $7,751.00 08/11/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697819
Principal investigator 1 Medtronic, Inc. $294.00 08/10/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694843
Principal investigator 1 Novo Nordisk AS $23.06 08/09/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701273
Principal investigator 1 Novo Nordisk AS $1,571.91 08/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238433
Principal investigator 1 Novo Nordisk AS $23.06 08/03/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701249
Principal investigator 1 Novo Nordisk AS $23.06 08/02/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385417
Principal investigator 1 Medtronic, Inc. $135.00 07/31/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697821
Principal investigator 1 Novo Nordisk AS $2,948.40 07/31/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007313787
Principal investigator 1 Novo Nordisk AS $2,716.87 07/31/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985035
Principal investigator 1 Medtronic, Inc. $378.00 07/28/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694841
Principal investigator 1 Medtronic, Inc. $1,615.00 07/25/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700601
Principal investigator 1 Medtronic, Inc. $168.00 07/20/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694839
Principal investigator 1 Medtronic, Inc. $1,523.00 07/14/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694837
Principal investigator 1 Novo Nordisk AS $7.27 07/07/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1006946703
Principal investigator 1 Novo Nordisk AS $23.06 07/07/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1006946711
Principal investigator 1 Novo Nordisk AS $10.00 07/03/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008713191
Principal investigator 1 Novo Nordisk AS $23.06 07/03/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008713205
Principal investigator 1 Medtronic, Inc. $2,158.71 06/30/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993703993
Principal investigator 1 Medtronic, Inc. $23,333.11 06/30/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993703997
Principal investigator 1 Medtronic, Inc. $17,398.31 06/30/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993704001
Principal investigator 1 Medtronic, Inc. $3,069.75 06/30/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993704003
Principal investigator 1 Novo Nordisk AS $7.27 06/28/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385681
Principal investigator 1 Novo Nordisk AS $23.06 06/28/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385695
Principal investigator 1 Medtronic, Inc. $348.00 06/27/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694835
Principal investigator 1 Novo Nordisk AS $982.80 06/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008985017
Principal investigator 1 Novo Nordisk AS $787.50 06/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039855
Principal investigator 1 Novo Nordisk AS $1,491.77 06/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238411
Principal investigator 1 Novo Nordisk AS $23.06 06/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385709
Principal investigator 1 Novo Nordisk AS $10.00 06/19/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008713159
Principal investigator 1 Novo Nordisk AS $23.06 06/19/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008713175
Principal investigator 1 Medtronic, Inc. $2,310.00 06/14/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694833
Principal investigator 1 Medtronic, Inc. $8,825.00 06/14/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697817
Principal investigator 1 Medtronic, Inc. $1,773.00 06/09/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700617
Principal investigator 1 Novo Nordisk AS $23.06 06/07/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1006946691
Principal investigator 1 Novo Nordisk AS $10.00 06/06/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890267
Principal investigator 1 Novo Nordisk AS $23.06 06/06/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008713143
Principal investigator 1 Novo Nordisk AS $32.08 06/02/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385653
Principal investigator 1 Novo Nordisk AS $15.80 06/02/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385667
Principal investigator 1 Medtronic, Inc. $168.00 05/31/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694831
Principal investigator 1 Novo Nordisk AS $14.54 05/30/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385607
Principal investigator 1 Novo Nordisk AS $10.00 05/26/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890227
Principal investigator 1 Novo Nordisk AS $23.06 05/26/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890237
Principal investigator 1 Novo Nordisk AS $1,063.12 05/26/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1008999485
Principal investigator 1 Novo Nordisk AS $1,491.77 05/26/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238395
Principal investigator 1 Medtronic, Inc. $4,478.32 05/24/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688027
Principal investigator 1 Novo Nordisk AS $23.06 05/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701369
Principal investigator 1 Novo Nordisk AS $23.06 05/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385637
Principal investigator 1 Medtronic, Inc. $8,117.00 05/17/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697815
Principal investigator 1 Medtronic, Inc. $5,894.00 05/15/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694829
Principal investigator 1 Novo Nordisk AS $10.00 05/15/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890247
Principal investigator 1 Novo Nordisk AS $23.06 05/15/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890257
Principal investigator 1 Novo Nordisk AS $23.06 05/10/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385593
Principal investigator 1 Novo Nordisk AS $23.06 05/04/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385623
Principal investigator 1 Medtronic, Inc. $2,336.07 05/02/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688025
Principal investigator 1 Medtronic, Inc. $2,064.00 04/29/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP341 IMPACT2 No dispute reported 06/30/2026 993700615
Principal investigator 1 Novo Nordisk AS $5.20 04/28/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039805
Principal investigator 1 Novo Nordisk AS $23.06 04/28/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039821
Principal investigator 1 Novo Nordisk AS $708.75 04/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039837
Principal investigator 1 Novo Nordisk AS $1,118.83 04/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238377
Principal investigator 1 Medtronic, Inc. $2,131.00 04/19/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694827
Principal investigator 1 Novo Nordisk AS $9.00 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307151
Principal investigator 1 Novo Nordisk AS $18.00 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307161
Principal investigator 1 Novo Nordisk AS $89.28 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307173
Principal investigator 1 Novo Nordisk AS $97.80 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307183
Principal investigator 1 Novo Nordisk AS $12.20 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307193
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701309
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701321
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701333
Principal investigator 1 Novo Nordisk AS $39.80 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701345
Principal investigator 1 Novo Nordisk AS $55.80 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007701357
Principal investigator 1 Novo Nordisk AS $15.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385461
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385477
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385491
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385507
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385521
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385535
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385549
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385563
Principal investigator 1 Novo Nordisk AS $37.60 04/17/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385579
Principal investigator 1 Medtronic, Inc. $270.00 04/11/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697807
Principal investigator 1 Medtronic, Inc. $2,948.00 04/11/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697809
Principal investigator 1 Novo Nordisk AS $23.06 04/07/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1007307139
Principal investigator 1 Novo Nordisk AS $23.06 03/29/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1006946731
Principal investigator 1 Medtronic, Inc. $86.36 03/28/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688023
Principal investigator 1 Medtronic, Inc. $6,260.00 03/28/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697805
Principal investigator 1 Medtronic, Inc. $234.00 03/27/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP337 SUCCEED No dispute reported 06/30/2026 993697803
Principal investigator 1 Medtronic, Inc. $5,009.00 03/24/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694825
Principal investigator 1 Novo Nordisk AS $1,708.33 03/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385387
Principal investigator 1 Novo Nordisk AS $354.37 03/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039787
Principal investigator 1 Novo Nordisk AS $23.06 03/23/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1009238361
Principal investigator 1 Novo Nordisk AS $23.06 03/08/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1006946722
Principal investigator 1 Medtronic, Inc. $4,435.14 03/03/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688021
Principal investigator 1 Novo Nordisk AS $1,355.35 02/24/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385371
Principal investigator 1 Novo Nordisk AS $1,782.00 02/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890219
Principal investigator 1 Novo Nordisk AS $23.06 02/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385449
Principal investigator 1 Novo Nordisk AS $2,666.25 02/22/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1009039771
Principal investigator 1 Medtronic, Inc. $1,820.00 02/21/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694823
Principal investigator 1 Novo Nordisk AS $23.06 02/20/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385431
Principal investigator 1 Medtronic, Inc. $84.00 02/15/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694821
Principal investigator 1 Medtronic, Inc. $212.00 02/08/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688019
Principal investigator 1 Medtronic, Inc. $84.00 02/07/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694819
Principal investigator 1 Novo Nordisk AS $23.06 02/02/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385403
Principal investigator 1 Novo Nordisk AS $2,170.80 01/25/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1006890211
Principal investigator 1 Novo Nordisk AS $1,541.25 01/25/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007870411
Principal investigator 1 Novo Nordisk AS $2,690.74 01/25/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008385357
Principal investigator 1 Medtronic, Inc. $2,195.98 01/24/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688017
Principal investigator 1 Medtronic, Inc. $2,604.00 01/20/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694817
Principal investigator 1 Novo Nordisk AS $23.06 01/06/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 1008399717
Principal investigator 1 Medtronic, Inc. $86.36 01/04/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 993688015
Principal investigator 1 Medtronic, Inc. $126.00 01/03/2023 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 993694815
Principal investigator 1 Novo Nordisk AS $23.06 01/03/2023 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 1007870405